Concetta Potenza

Semaglutide in Patients with Obesity and Psoriasis: Insights from an 18-Month Real-World Experience

Psoriasis is often associated with obesity and type 2 diabetes mellitus (T2DM) due to a common low-grade chronic inflammatory mechanism amplified by metabolic dysfunction. Biologics have revolutionized psoriasis treatment, but patients with obesity show reduced responses and high...